☰

Philippe Beutels, Ph.D. - Publications

Affiliations: 
2002 Universitaire Instelling Antwerpen (Belgium) 
Area:
Public Health, General Economics
Tree Info Similar researchers PubMed Report error

48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Affaticati F, Bartholomeus E, Mullan K, Damme PV, Beutels P, Ogunjimi B, Laukens K, Meysman P. Multi-View Learning to Unravel the Different Levels Underlying Hepatitis B Vaccine Response. Vaccines. 11. PMID 37515051 DOI: 10.3390/vaccines11071236  0.581
2023 Koltai M, Moyes J, Nyawanda B, Nyiro J, Munywoki PK, Tempia S, Li X, Antillon M, Bilcke J, Flasche S, Beutels P, Nokes DJ, Cohen C, Jit M. Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa. Bmc Medicine. 21: 120. PMID 37004062 DOI: 10.1186/s12916-023-02806-w  0.348
2022 Varbanova V, Verelst F, Hens N, Beutels P. Determinants of basic childhood vaccination coverage in European and OECD countries. Human Vaccines & Immunotherapeutics. 2123883. PMID 36173818 DOI: 10.1080/21645515.2022.2123883  0.305
2022 Mazur NI, Terstappen J, Baral R, Bardají A, Beutels P, Buchholz UJ, Cohen C, Crowe JE, Cutland CL, Eckert L, Feikin D, Fitzpatrick T, Fong Y, Graham BS, Heikkinen T, et al. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. The Lancet. Infectious Diseases. PMID 35952703 DOI: 10.1016/S1473-3099(22)00291-2  0.302
2022 Luyten J, Beutels P, Vandermeulen C, Kessels R. Social preferences for adopting new vaccines in the national immunization program: A discrete choice experiment. Social Science & Medicine (1982). 303: 114991. PMID 35594739 DOI: 10.1016/j.socscimed.2022.114991  0.307
2022 Franco N, Coletti P, Willem L, Angeli L, Lajot A, Abrams S, Beutels P, Faes C, Hens N. Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data. Plos Computational Biology. 18: e1009965. PMID 35353810 DOI: 10.1371/journal.pcbi.1009965  0.386
2021 Iftekhar EN, Priesemann V, Balling R, Bauer S, Beutels P, Calero Valdez A, Cuschieri S, Czypionka T, Dumpis U, Glaab E, Grill E, Hanson C, Hotulainen P, Klimek P, Kretzschmar M, et al. A look into the future of the COVID-19 pandemic in Europe: an expert consultation. The Lancet Regional Health. Europe. 100185. PMID 34345876 DOI: 10.1016/j.lanepe.2021.100185  0.306
2020 Bartholomeus E, De Neuter N, Suls A, Elias G, van der Heijden S, Keersmaekers N, Jansens H, Van Tendeloo V, Beutels P, Laukens K, Ogunjimi B, Mortier G, Meysman P, Van Damme P. Transcriptomic profiling of different responder types in adults after a Priorix® vaccination. Vaccine. PMID 32165045 DOI: 10.1016/j.vaccine.2020.03.004  0.3
2019 Keersmaekers N, Ogunjimi B, Van Damme P, Beutels P, Hens N. An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with Varilrix. Vaccine. PMID 30975567 DOI: 10.1016/j.vaccine.2019.03.075  0.306
2018 Willem L, Blommaert A, Hanquet G, Thiry N, Bilcke J, Theeten H, Verhaegen J, Goossens H, Beutels P. Economic Evaluation of Pneumococcal Vaccines for Adults Aged Over 50 Years in Belgium. Human Vaccines & Immunotherapeutics. 0. PMID 29420161 DOI: 10.1080/21645515.2018.1428507  0.339
2016 Abrams S, Kourkouni E, Sabbe M, Beutels P, Hens N. Inferring rubella outbreak risk from seroprevalence data in Belgium. Vaccine. PMID 27840011 DOI: 10.1016/J.Vaccine.2016.10.072  0.32
2016 Sabbe M, Berger N, Blommaert A, Ogunjimi B, Grammens T, Callens M, Van Herck K, Beutels P, Van Damme P, Bilcke J. Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014. Euro Surveillance : Bulletin EuropéEn Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 21. PMID 27418466 DOI: 10.2807/1560-7917.Es.2016.21.27.30273  0.312
2016 Dirmesropian S, Wood JG, MacIntyre CR, Beutels P, Newall AT. Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges. Pharmacoeconomics. PMID 26914091 DOI: 10.1007/s40273-016-0393-0  0.338
2015 Goeyvaerts N, Willem L, Van Kerckhove K, Vandendijck Y, Hanquet G, Beutels P, Hens N. Estimating dynamic transmission model parameters for seasonal influenza by fitting to age and season-specific influenza-like illness incidence. Epidemics. 13: 1-9. PMID 26616037 DOI: 10.1016/J.Epidem.2015.04.002  0.328
2015 Ogunjimi B, Willem L, Beutels P, Hens N. Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster. Elife. 4. PMID 26259874 DOI: 10.7554/Elife.07116  0.373
2015 Hens N, Abrams S, Santermans E, Theeten H, Goeyvaerts N, Lernout T, Leuridan E, Van Kerckhove K, Goossens H, Van Damme P, Beutels P. Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013 Euro Surveillance : Bulletin EuropéEn Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 20. PMID 25613653 DOI: 10.2807/1560-7917.Es2015.20.1.20998  0.325
2015 Santermans E, Goeyvaerts N, Melegaro A, Edmunds WJ, Faes C, Aerts M, Beutels P, Hens N. The social contact hypothesis under the assumption of endemic equilibrium: Elucidating the transmission potential of VZV in Europe Epidemics. 11: 14-23. DOI: 10.1016/J.Epidem.2014.12.005  0.395
2014 Luyten J, Ogunjimi B, Beutels P. Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives. Vaccine. 32: 7175-8. PMID 25454883 DOI: 10.1016/j.vaccine.2014.10.015  0.3
2014 Abrams S, Beutels P, Hens N. Assessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data. American Journal of Epidemiology. 179: 1006-17. PMID 24573540 DOI: 10.1093/Aje/Kwu014  0.317
2014 Theeten H, Hutse V, Hoppenbrouwers K, Beutels P, Van Damme P. Universal hepatitis B vaccination in Belgium: Impact on serological markers 3 and 7 years after implementation Epidemiology and Infection. 142: 251-261. PMID 23689103 DOI: 10.1017/S0950268813001064  0.365
2013 Ogunjimi B, Van Damme P, Beutels P. Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review. Plos One. 8: e66485. PMID 23805224 DOI: 10.1371/journal.pone.0066485  0.303
2013 Jit M, Newall AT, Beutels P. Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies. Human Vaccines & Immunotherapeutics. 9: 834-40. PMID 23357859 DOI: 10.4161/hv.23637  0.344
2013 Bilcke J, van Hoek AJ, Beutels P. Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting? Human Vaccines & Immunotherapeutics. 9: 812-22. PMID 23321955 DOI: 10.4161/Hv.23334  0.313
2012 Newall AT, Jit M, Beutels P. Economic evaluations of childhood influenza vaccination: a critical review. Pharmacoeconomics. 30: 647-60. PMID 22788257 DOI: 10.2165/11599130-000000000-00000  0.336
2012 Goeyvaerts N, Hens N, Theeten H, Aerts M, Van Damme P, Beutels P. Estimating vaccination coverage for the trivalent measles-mumps-rubella vaccine from trivariate serological data. Statistics in Medicine. 31: 1432-49. PMID 22362265 DOI: 10.1002/Sim.4481  0.36
2012 Bilcke J, Marais C, Ogunjimi B, Willem L, Hens N, Beutels P. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium. Vaccine. 30: 675-84. PMID 22120193 DOI: 10.1016/J.Vaccine.2011.10.036  0.305
2012 Bilcke J, Ogunjimi B, Hulstaert F, Van Damme P, Hens N, Beutels P. Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice? Vaccine. 30: 2795-800. PMID 21964056 DOI: 10.1016/J.Vaccine.2011.09.079  0.349
2012 Bollaerts K, Aerts M, Shkedy Z, Faes C, van der Stede Y, Beutels P, Hens N. Estimating the population prevalence and force of infection directly from antibody titres Statistical Modelling. 12: 441-462. DOI: 10.1177/1471082X12457495  0.324
2011 Goeyvaerts N, Hens N, Aerts M, Beutels P. Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19. Biostatistics (Oxford, England). 12: 283-302. PMID 20841333 DOI: 10.1093/Biostatistics/Kxq059  0.389
2011 Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium Epidemiology and Infection. 139: 494-504. PMID 20587123 DOI: 10.1017/S0950268810001536  0.356
2010 Hens N, Aerts M, Faes C, Shkedy Z, Lejeune O, Van Damme P, Beutels P. Seventy-five years of estimating the force of infection from current status data Epidemiology and Infection. 138: 802-812. PMID 19765352 DOI: 10.1017/S0950268809990781  0.333
2010 Goeyvaerts N, Hens N, Ogunjimi B, Aerts M, Shkedy Z, Damme PV, Beutels P. Estimating infectious disease parameters from data on social contacts and serological status Journal of the Royal Statistical Society. Series C: Applied Statistics. 59: 255-277. DOI: 10.1111/J.1467-9876.2009.00693.X  0.594
2009 Bilcke J, Van Damme P, Van Ranst M, Hens N, Aerts M, Beutels P. Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis. Plos One. 4: e6060. PMID 19557133 DOI: 10.1371/Journal.Pone.0006060  0.345
2009 Ogunjimi B, Hens N, Goeyvaerts N, Aerts M, Van Damme P, Beutels P. Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicella. Mathematical Biosciences. 218: 80-7. PMID 19174173 DOI: 10.1016/J.Mbs.2008.12.009  0.374
2009 Effelterre TV, Shkedy Z, Aerts M, Molenberghs G, Damme PV, Beutels P. Contact patterns and their implied basic reproductive numbers: an illustration for varicella-zoster virus. Epidemiology and Infection. 137: 48-57. PMID 18466660 DOI: 10.1017/S0950268808000563  0.577
2008 Beutels P, Scuffham PA, MacIntyre CR. Funding of drugs: do vaccines warrant a different approach? The Lancet. Infectious Diseases. 8: 727-33. PMID 18992409 DOI: 10.1016/S1473-3099(08)70258-5  0.307
2007 Namata H, Shkedy Z, Faes C, Aerts M, Molenberghs G, Theeten H, van Damme P, Beutels P. Estimation of the force of infection from current status data using generalized linear mixed models Journal of Applied Statistics. 34: 923-939. DOI: 10.1080/02664760701590525  0.314
2005 Thiry N, Beutels P, Van Damme P. Economic evaluations of pneumococcal vaccination strategies in adults. A summary of the results Acta Clinica Belgica. 60: 338-344. PMID 16502594 DOI: 10.1179/acb.2005.051  0.31
2005 Macartney KK, Beutels P, McIntyre P, Burgess MA. Varicella vaccination in Australia Journal of Paediatrics and Child Health. 41: 544-552. PMID 16398834 DOI: 10.1111/j.1440-1754.2005.00717.x  0.314
2003 Postma MJ, Heijnen MLA, Beutels P, Jager JC. Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: Cost-effectiveness analyses and implications for the Netherlands Expert Review of Vaccines. 2: 477-482. PMID 14711333 DOI: 10.1586/14760584.2.4.477  0.324
2003 Thiry N, Beutels P, Van Damme P, Van Doorslaer E. Economic evaluations of varicella vaccination programmes: A review of the literature Pharmacoeconomics. 21: 13-38. PMID 12484801 DOI: 10.2165/00019053-200321010-00002  0.316
2003 Shkedy Z, Aerts M, Molenberghs G, Beutels P, Van Damme P. Modelling forces of infection by using monotone local polynomials Journal of the Royal Statistical Society. Series C: Applied Statistics. 52: 469-485. DOI: 10.1111/1467-9876.00418  0.328
2003 Bonanni P, Beutels P, Bechini A, Maci M. Economic evaluation of increased vaccination coverage against pertussis in Tuscany: A preliminary study Pharmacoeconomics - Italian Research Articles. 5: 1-11.  0.302
2002 Thiry N, Beutels P, Shkedy Z, Vranckx R, Vandermeulen C, Wielen MV, Damme PV. The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium). European Journal of Pediatrics. 161: 588-93. PMID 12424583 DOI: 10.1007/s00431-002-1053-2  0.578
2002 Beutels P, Edmunds WJ, Antoñanzas F, De Wit GA, Evans D, Feilden R, Fendrick AM, Ginsberg GM, Glick HA, Mast E, Péchevis M, Van Doorslaer EK, van Hout BA. Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis. Pharmacoeconomics. 20: 1-7. PMID 11817988  0.31
2000 Van Herck K, Beutels P, Van Damme P, Beutels M, Van Den Dries J, Briantais P, Vidor E. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines Journal of Medical Virology. 60: 1-7. PMID 10568755 DOI: 10.1002/(SICI)1096-9071(200001)60:1<1::AID-JMV1>3.0.CO;2-H  0.319
1996 Gutersohn T, Steffen R, Van Damme P, Holdener F, Beutels P. Hepatitis A infection in aircrews: Risk of infection and cost-benefit analysis of hepatitis A vaccination Aviation Space and Environmental Medicine. 67: 153-156. PMID 8834941  0.301
1995 Van Damme P, Tormans G, Beutels P, Van Doorslaer E. Hepatitis B prevention in Europe: a preliminary economic evaluation Vaccine. 13. PMID 7571833 DOI: 10.1016/0264-410X(95)80053-G  0.33
Show low-probability matches.